bluebird bio Management
Management criteria checks 2/4
bluebird bio's CEO is Andrew Obenshain, appointed in Jan 2021, has a tenure of 3.42 years. total yearly compensation is $1.81M, comprised of 35.5% salary and 64.5% bonuses, including company stock and options. directly owns 0.085% of the company’s shares, worth $148.09K. The average tenure of the management team and the board of directors is 1.8 years and 13.3 years respectively.
Key information
Andrew Obenshain
Chief executive officer
US$1.8m
Total compensation
CEO salary percentage | 35.5% |
CEO tenure | 3.4yrs |
CEO ownership | 0.09% |
Management average tenure | 1.8yrs |
Board average tenure | 13.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | -US$91m |
Jun 30 2023 | n/a | n/a | -US$96m |
Mar 31 2023 | n/a | n/a | -US$123m |
Dec 31 2022 | US$2m | US$643k | -US$267m |
Sep 30 2022 | n/a | n/a | -US$431m |
Jun 30 2022 | n/a | n/a | -US$507m |
Mar 31 2022 | n/a | n/a | -US$563m |
Dec 31 2021 | US$9m | US$486k | -US$563m |
Compensation vs Market: Andrew's total compensation ($USD1.81M) is above average for companies of similar size in the UK market ($USD732.55K).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew Obenshain (50 yo)
3.4yrs
Tenure
US$1,814,700
Compensation
Mr. Andrew Obenshain has been the Chief Executive Officer and Director of bluebird bio, Inc. since 2021 and serves as its President. He served as President of Severe Genetic Diseases since October 2020 unt...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 3.4yrs | US$1.81m | 0.085% $ 148.1k | |
Chief Commercial Officer & COO | 1.8yrs | US$1.25m | 0.065% $ 112.8k | |
Chief Medical Officer | 3.3yrs | US$1.36m | 0.023% $ 39.2k | |
CFO, Principal Accounting Officer & Treasurer | 1.6yrs | no data | 0.0041% $ 7.2k | |
Chief Legal & Business Officer and Secretary | 1.4yrs | no data | 0.0038% $ 6.6k | |
Head of Corporate Communications | 1.5yrs | no data | no data | |
Chief People Officer | 2.4yrs | no data | no data | |
Senior Vice President of Technical Development & Operations | no data | no data | no data | |
Senior Vice President of Quality | 3.4yrs | no data | no data | |
Senior Vice President of External Affairs | 1.5yrs | no data | no data | |
VP & Global Controller | no data | no data | no data | |
Investor Relations Officer | no data | no data | no data |
1.8yrs
Average Tenure
51yo
Average Age
Experienced Management: 0HOH's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 3.4yrs | US$1.81m | 0.085% $ 148.1k | |
Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
Co-Chair of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
Independent Chairman | 9.9yrs | US$142.23k | 0.0074% $ 12.9k | |
Member of Scientific Advisory Board | 8.9yrs | US$1.57m | no data | |
Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
Independent Director | 7yrs | US$91.31k | 0.0081% $ 14.2k | |
Director | 14.3yrs | US$27.31k | 0.23% $ 405.5k | |
Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
Independent Director | 2.6yrs | US$97.81k | 0.0043% $ 7.6k |
13.3yrs
Average Tenure
65yo
Average Age
Experienced Board: 0HOH's board of directors are seasoned and experienced ( 13.3 years average tenure).